About Zhejiang Conba Pharmaceutical Company

The company was formerly known as Lanxi Yunshan Pharmaceutical Factory. After more than 50 years of development, it has now grown into the largest traditional Chinese medicine enterprise (SH600572) in the province integrating drug research and development, production and sales. It ranks among the top 10 Chinese medicine enterprises in China, and has been selected as a “model enterprise for scientific reform” of state-owned enterprises under the State Council. The controlling shareholder of the company is Zhejiang Traditional Chinese Medicine and Health Industry Group Co., Ltd. (a wholly-owned subsidiary of Zhejiang International Trade Group Co., Ltd.). The company focuses on the main medical and health business, mainly engaged in R&D, manufacturing and sales of pharmaceuticals, Chinese herbal medicine tablets and health products. It adheres to the industrial development strategy with traditional Chinese medicine health as the core business, and the “one two wings” product business position with all categories of traditional Chinese medicine products as the main body, specialty chemicals and specialty health consumer products as the two wings. All categories of traditional Chinese medicine products include proprietary Chinese medicines, Chinese herbal medicines and Chinese medicine tablets, traditional Chinese medicine health products and traditional Chinese medicine extracts; the specialty chemicals sector mainly includes specialty chemical preparations and APIs; the specialty health consumer goods sector mainly focuses on online businesses such as nutritional supplements. Corporate honors: Hu Jiqiang won the “Global Zhejiang Merchants Gold Award”, the 11th China Main Board Listed Company Top 100 Value Gold Award, the Zhejiang Red Cross Fraternity Merit Gold Award, 2016 Advanced Unit for the Integration of “Two Modernizations”, and the 2017 China Top 500 Brands Ranking, Conn Bell ranked 312th.